Recombinant Human ALDH1L2 Protein，His

ALDH1L2 (Aldehyde Dehydrogenase 1 Family Member L2) is an important enzyme involved in folate metabolism and is crucial for maintaining cellular redox homeostasis and methylation processes. Research has indicated that ALDH1L2 plays a significant role in various cellular functions, including proliferation, differentiation, and apoptosis, particularly within the context of cancer. Its expression levels have been linked to tumor progression and patient prognosis, rendering it a potential biomarker and therapeutic target in oncological studies. The study of recombinant ALDH1L2 proteins aims to elucidate the enzyme's structural and functional characteristics, which can provide insights into its role in metabolic pathways and its implications in disease pathology. By expressing ALDH1L2 in a recombinant system, researchers can obtain sufficient quantities of the protein for detailed biochemical assays, functional studies, and high-resolution structural analyses. Understanding the catalytic mechanisms and substrate specificity of ALDH1L2 is critical for developing inhibitors or modulators that could be used in cancer therapy or to treat conditions related to dysregulated folate metabolism. Emerging data suggest that manipulating ALDH1L2 activity could influence cancer cell survival and sensitivity to chemotherapy. Therefore, the research background of ALDH1L2 recombinant proteins is grounded in its potential applications in therapeutic development, as well as its fundamental importance in the regulation of cellular metabolism and its associated diseases. By targeting this enzyme, researchers hope to uncover novel strategies for intervention in cancer treatment and to enhance the understanding of metabolic dysregulation in various pathologies.